Nicholas Investment Partners, LP Global Blood Therapeutics, Inc. Transaction History

Nicholas Investment Partners, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$37.65 - $63.77 $7.13 Million - $12.1 Million	-189,392 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$52.76 - $74.49 $8.03 Million - $11.3 Million	152,293 Added 410.5%	189,392 $10.4 Million
Q2 2020 Aug 12, 2020	SELL	$48.73 - $81.82 $1.92 Million - $3.23 Million	-39,497 Reduced 51.57%	37,099 $2.34 Million
Q1 2020 May 13, 2020	BUY	$41.72 - $87.2 $387,203 - $809,303	9,281 Added 13.79%	76,596 $3.91 Million
Q4 2019 Feb 13, 2020	SELL	$45.7 - $81.86 $1.24 Million - $2.21 Million	-27,048 Reduced 28.66%	67,315 $5.35 Million
Q3 2019 Nov 13, 2019	BUY	$45.35 - $57.91 $266,884 - $340,800	5,885 Added 6.65%	94,363 $4.58 Million
Q2 2019 Aug 09, 2019	BUY	$52.6 - $63.29 $1 Million - $1.21 Million	19,090 Added 27.51%	88,478 $4.65 Million
Q1 2019 May 15, 2019	BUY	$39.99 - $53.48 $2.38 Million - $3.19 Million	59,581 Added 607.54%	69,388 $3.67 Million
Q4 2018 Feb 14, 2019	SELL	$31.54 - $46.67 $3.01 Million - $4.45 Million	-95,316 Reduced 90.67%	9,807 $403,000
Q3 2018 Nov 14, 2018	SELL	$38.0 - $51.1 $43,662 - $58,713	-1,149 Reduced 1.08%	105,123 $4 Million
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $2.28 Million - $2.96 Million	58,994 Added 124.78%	106,272 $4.8 Million
Q1 2018 May 15, 2018	SELL	$39.6 - $65.9 $273,042 - $454,380	-6,895 Reduced 12.73%	47,278 $2.28 Million
Q4 2017 Feb 14, 2018	BUY	$29.7 - $45.7 $1.61 Million - $2.48 Million	54,173	54,173 $2.13 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.